Machine learning algorithms based on proteomic data mining accurately predicting the recurrence of hepatitis B‐related hepatocellular carcinoma
Background and Aim Over 10% of hepatocellular carcinoma (HCC) cases recur each year, even after surgical resection. Currently, there is a lack of knowledge about the causes of recurrence and the effective prevention. Prediction of HCC recurrence requires diagnostic markers endowed with high sensitiv...
Saved in:
Published in | Journal of gastroenterology and hepatology Vol. 37; no. 11; pp. 2145 - 2153 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Richmond
Wiley Subscription Services, Inc
01.11.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background and Aim
Over 10% of hepatocellular carcinoma (HCC) cases recur each year, even after surgical resection. Currently, there is a lack of knowledge about the causes of recurrence and the effective prevention. Prediction of HCC recurrence requires diagnostic markers endowed with high sensitivity and specificity. This study aims to identify new key proteins for HCC recurrence and to build machine learning algorithms for predicting HCC recurrence.
Methods
The proteomics data for analysis in this study were obtained from the Clinical Proteomics Tumor Analysis Consortium (CPTAC) database. We analyzed different proteins based on cases with or without recurrence of HCC. Survival analysis, Cox regression analysis, and area under the ROC curves (AUROC > 0.7) were used to screen for more significant differential proteins. Predictive models for HCC recurrence were developed using four machine learning algorithms.
Results
A total of 690 differentially expressed proteins between 50 relapsed and 77 non‐relapsed hepatitis B‐related HCC patients were identified. Seven of these proteins had an AUROC > 0.7 for 5‐year survival in HCC, including BAHCC1, ESF1, RAP1GAP, RUFY1, SCAMP3, STK3, and TMEM230. Among the machine learning algorithms, the random forest algorithm showed the highest AUROC values (AUROC: 0.991, 95% CI 0.962–0.999) for identifying HCC recurrence, followed by the support vector machine (AUROC: 0.893, 95% Cl 0.824–0.956), the logistic regression (AUROC: 0.774, 95% Cl 0.672–0.868), and the multi‐layer perceptron algorithm (AUROC: 0.571, 95% Cl 0.459–0.682).
Conclusions
Our study identifies seven novel proteins for predicting HCC recurrence and the random forest algorithm as the most suitable predictive model for HCC recurrence. |
---|---|
AbstractList | Over 10% of hepatocellular carcinoma (HCC) cases recur each year, even after surgical resection. Currently, there is a lack of knowledge about the causes of recurrence and the effective prevention. Prediction of HCC recurrence requires diagnostic markers endowed with high sensitivity and specificity. This study aims to identify new key proteins for HCC recurrence and to build machine learning algorithms for predicting HCC recurrence.BACKGROUND AND AIMOver 10% of hepatocellular carcinoma (HCC) cases recur each year, even after surgical resection. Currently, there is a lack of knowledge about the causes of recurrence and the effective prevention. Prediction of HCC recurrence requires diagnostic markers endowed with high sensitivity and specificity. This study aims to identify new key proteins for HCC recurrence and to build machine learning algorithms for predicting HCC recurrence.The proteomics data for analysis in this study were obtained from the Clinical Proteomics Tumor Analysis Consortium (CPTAC) database. We analyzed different proteins based on cases with or without recurrence of HCC. Survival analysis, Cox regression analysis, and area under the ROC curves (AUROC > 0.7) were used to screen for more significant differential proteins. Predictive models for HCC recurrence were developed using four machine learning algorithms.METHODSThe proteomics data for analysis in this study were obtained from the Clinical Proteomics Tumor Analysis Consortium (CPTAC) database. We analyzed different proteins based on cases with or without recurrence of HCC. Survival analysis, Cox regression analysis, and area under the ROC curves (AUROC > 0.7) were used to screen for more significant differential proteins. Predictive models for HCC recurrence were developed using four machine learning algorithms.A total of 690 differentially expressed proteins between 50 relapsed and 77 non-relapsed hepatitis B-related HCC patients were identified. Seven of these proteins had an AUROC > 0.7 for 5-year survival in HCC, including BAHCC1, ESF1, RAP1GAP, RUFY1, SCAMP3, STK3, and TMEM230. Among the machine learning algorithms, the random forest algorithm showed the highest AUROC values (AUROC: 0.991, 95% CI 0.962-0.999) for identifying HCC recurrence, followed by the support vector machine (AUROC: 0.893, 95% Cl 0.824-0.956), the logistic regression (AUROC: 0.774, 95% Cl 0.672-0.868), and the multi-layer perceptron algorithm (AUROC: 0.571, 95% Cl 0.459-0.682).RESULTSA total of 690 differentially expressed proteins between 50 relapsed and 77 non-relapsed hepatitis B-related HCC patients were identified. Seven of these proteins had an AUROC > 0.7 for 5-year survival in HCC, including BAHCC1, ESF1, RAP1GAP, RUFY1, SCAMP3, STK3, and TMEM230. Among the machine learning algorithms, the random forest algorithm showed the highest AUROC values (AUROC: 0.991, 95% CI 0.962-0.999) for identifying HCC recurrence, followed by the support vector machine (AUROC: 0.893, 95% Cl 0.824-0.956), the logistic regression (AUROC: 0.774, 95% Cl 0.672-0.868), and the multi-layer perceptron algorithm (AUROC: 0.571, 95% Cl 0.459-0.682).Our study identifies seven novel proteins for predicting HCC recurrence and the random forest algorithm as the most suitable predictive model for HCC recurrence.CONCLUSIONSOur study identifies seven novel proteins for predicting HCC recurrence and the random forest algorithm as the most suitable predictive model for HCC recurrence. Background and Aim Over 10% of hepatocellular carcinoma (HCC) cases recur each year, even after surgical resection. Currently, there is a lack of knowledge about the causes of recurrence and the effective prevention. Prediction of HCC recurrence requires diagnostic markers endowed with high sensitivity and specificity. This study aims to identify new key proteins for HCC recurrence and to build machine learning algorithms for predicting HCC recurrence. Methods The proteomics data for analysis in this study were obtained from the Clinical Proteomics Tumor Analysis Consortium (CPTAC) database. We analyzed different proteins based on cases with or without recurrence of HCC. Survival analysis, Cox regression analysis, and area under the ROC curves (AUROC > 0.7) were used to screen for more significant differential proteins. Predictive models for HCC recurrence were developed using four machine learning algorithms. Results A total of 690 differentially expressed proteins between 50 relapsed and 77 non‐relapsed hepatitis B‐related HCC patients were identified. Seven of these proteins had an AUROC > 0.7 for 5‐year survival in HCC, including BAHCC1, ESF1, RAP1GAP, RUFY1, SCAMP3, STK3, and TMEM230. Among the machine learning algorithms, the random forest algorithm showed the highest AUROC values (AUROC: 0.991, 95% CI 0.962–0.999) for identifying HCC recurrence, followed by the support vector machine (AUROC: 0.893, 95% Cl 0.824–0.956), the logistic regression (AUROC: 0.774, 95% Cl 0.672–0.868), and the multi‐layer perceptron algorithm (AUROC: 0.571, 95% Cl 0.459–0.682). Conclusions Our study identifies seven novel proteins for predicting HCC recurrence and the random forest algorithm as the most suitable predictive model for HCC recurrence. Background and AimOver 10% of hepatocellular carcinoma (HCC) cases recur each year, even after surgical resection. Currently, there is a lack of knowledge about the causes of recurrence and the effective prevention. Prediction of HCC recurrence requires diagnostic markers endowed with high sensitivity and specificity. This study aims to identify new key proteins for HCC recurrence and to build machine learning algorithms for predicting HCC recurrence.MethodsThe proteomics data for analysis in this study were obtained from the Clinical Proteomics Tumor Analysis Consortium (CPTAC) database. We analyzed different proteins based on cases with or without recurrence of HCC. Survival analysis, Cox regression analysis, and area under the ROC curves (AUROC > 0.7) were used to screen for more significant differential proteins. Predictive models for HCC recurrence were developed using four machine learning algorithms.ResultsA total of 690 differentially expressed proteins between 50 relapsed and 77 non‐relapsed hepatitis B‐related HCC patients were identified. Seven of these proteins had an AUROC > 0.7 for 5‐year survival in HCC, including BAHCC1, ESF1, RAP1GAP, RUFY1, SCAMP3, STK3, and TMEM230. Among the machine learning algorithms, the random forest algorithm showed the highest AUROC values (AUROC: 0.991, 95% CI 0.962–0.999) for identifying HCC recurrence, followed by the support vector machine (AUROC: 0.893, 95% Cl 0.824–0.956), the logistic regression (AUROC: 0.774, 95% Cl 0.672–0.868), and the multi‐layer perceptron algorithm (AUROC: 0.571, 95% Cl 0.459–0.682).ConclusionsOur study identifies seven novel proteins for predicting HCC recurrence and the random forest algorithm as the most suitable predictive model for HCC recurrence. |
Author | Mi, Man He, Na Byrne, Christopher D Wang, Ke Yuan, Hai‐Yang Targher, Giovanni Xia, Harry Hua‐Xiang Feng, Gong Zhang, Xin‐Lei Zheng, Ming‐Hua Ye, Feng |
Author_xml | – sequence: 1 givenname: Gong surname: Feng fullname: Feng, Gong organization: The First Affiliated Hospital of Xi'an Jiaotong University – sequence: 2 givenname: Na surname: He fullname: He, Na organization: The First Affiliated Hospital of Xi'an Medical University – sequence: 3 givenname: Harry Hua‐Xiang surname: Xia fullname: Xia, Harry Hua‐Xiang organization: The First Affiliated Hospital of Guangdong Pharmaceutical University – sequence: 4 givenname: Man surname: Mi fullname: Mi, Man organization: Xi'an Medical University – sequence: 5 givenname: Ke surname: Wang fullname: Wang, Ke organization: Xi'an Medical University – sequence: 6 givenname: Christopher D surname: Byrne fullname: Byrne, Christopher D organization: University Hospital Southampton, Southampton General Hospital – sequence: 7 givenname: Giovanni surname: Targher fullname: Targher, Giovanni organization: University and Azienda Ospedaliera Universitaria Integrata of Verona – sequence: 8 givenname: Hai‐Yang surname: Yuan fullname: Yuan, Hai‐Yang organization: The First Affiliated Hospital of Wenzhou Medical University – sequence: 9 givenname: Xin‐Lei surname: Zhang fullname: Zhang, Xin‐Lei organization: The First Affiliated Hospital of Wenzhou Medical University – sequence: 10 givenname: Ming‐Hua orcidid: 0000-0003-4984-2631 surname: Zheng fullname: Zheng, Ming‐Hua email: zhengmh@wmu.edu.cn organization: Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province – sequence: 11 givenname: Feng surname: Ye fullname: Ye, Feng email: yefeng.jiaotong@xjtu.edu.cn organization: The First Affiliated Hospital of Xi'an Jiaotong University |
BookMark | eNp9kc9uFDEMxiNUJLaFA28QiQscpk3mXyZHqKAFFfVSzpGbeHayyiRLkhHaWx-hvCJPQpbhVAl8sWT_Psv2d0pOfPBIyGvOznmJi912OuedbNkzsuFtyyou2v6EbNjAu0o2XL4gpyntGGMtE92G_PwKerIeqUOI3votBbcN0eZpTvQeEhoaPN3HkDHMVlMDGehsV1LrJUJGdygAGqvzsZonpBFLJ6LXSMNIJ9xDttkm-uHXw2NEVzRmrQaNzi0OItUQtfVhhpfk-Qgu4au_-Yx8-_Tx7vK6urm9-nz5_qbSTcNY1YFhsh16wQahhexH5GN7bzqhBymQcd0biZKbXnMGgndNPfLBtGwcm67pBDRn5O06txz3fcGU1WzTcR3wGJak6n4Y2NBxLgr65gm6C0v0ZTtVi0bUNaulLNS7ldIxpBRxVPtoZ4gHxZk6mqOKOeqPOYW9eMJqm8uTgs8RrPuf4od1ePj3aPXl6npV_AaFKqWb |
CitedBy_id | crossref_primary_10_3389_fimmu_2024_1368749 crossref_primary_10_1186_s12014_024_09502_8 crossref_primary_10_3389_fmed_2022_1025887 crossref_primary_10_3389_fgene_2023_1004481 crossref_primary_10_1007_s11255_024_04351_8 crossref_primary_10_1038_s41746_023_00976_8 crossref_primary_10_3389_fonc_2023_1277772 |
Cites_doi | 10.1016/j.ccr.2006.06.016 10.1002/jhbp.972 10.1007/s00595-012-0167-z 10.1172/JCI88486 10.1016/j.gene.2020.144549 10.1186/s12938-020-00812-0 10.1016/j.jclepro.2018.08.207 10.32614/RJ-2015-018 10.1002/hep.31103 10.1016/j.canlet.2014.09.026 10.1097/MD.0000000000013923 10.4049/jimmunol.1800627 10.1016/j.jss.2012.01.025 10.3322/caac.21660 10.1016/j.tplants.2021.12.013 10.3390/metabo12010041 10.1016/j.neucom.2019.10.118 10.1111/jvh.13452 10.1159/000520961 10.1021/pr501254j 10.1016/j.ijbiomac.2022.01.011 10.1038/s41467-019-10364-0 10.3389/fimmu.2021.655697 10.1093/bioinformatics/btx812 10.1016/j.compbiolchem.2022.107625 10.1007/s12029-021-00730-x 10.18632/oncotarget.21208 10.1097/ALN.0000000000002960 10.1002/hep.31288 10.2217/fon-2021-0759 10.1016/S0140-6736(17)33326-3 10.1074/mcp.TIR119.001673 10.1016/j.csbj.2021.09.001 10.1016/j.yexcr.2019.03.005 10.1016/j.cell.2019.08.052 10.4103/2277-9175.180636 10.1016/j.hlc.2013.06.006 10.1021/acs.jcim.8b00338 10.1016/j.ebiom.2018.12.039 10.1002/hep.29904 |
ContentType | Journal Article |
Copyright | 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd |
Copyright_xml | – notice: 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. – notice: 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd |
DBID | AAYXX CITATION 7T5 7U9 H94 K9. 7X8 |
DOI | 10.1111/jgh.15940 |
DatabaseName | CrossRef Immunology Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1440-1746 |
EndPage | 2153 |
ExternalDocumentID | 10_1111_jgh_15940 JGH15940 |
Genre | article |
GrantInformation_xml | – fundername: Shaanxi Provincial Department of Education 2020 Special Scientific Research Plan for Emergency Public Health Safety funderid: 20JG028 – fundername: School of Medicine, University of Verona, Verona, Italy – fundername: Youth Project of Science and Technology Department of Shaanxi Province funderid: 2022JQ‐986 – fundername: 2021 school level scientific research project of Xi'an Medical University funderid: 2021QN20 – fundername: Southampton NIHR Biomedical Research Centre funderid: IS‐BRC‐20004 – fundername: Science and Technology Project of Shaanxi Province funderid: 2021ZDLSF02‐09 |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OB 1OC 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F D-I DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DTERQ DU5 EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO KMS LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOQ WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION 7T5 7U9 AAMMB AEFGJ AGXDD AIDQK AIDYY H94 K9. 7X8 |
ID | FETCH-LOGICAL-c3300-5ad094867087c796fe1f4bd57c897e01c6d9e91d6c10a71532f18d40ff35357a3 |
IEDL.DBID | DR2 |
ISSN | 0815-9319 1440-1746 |
IngestDate | Fri Jul 11 04:29:22 EDT 2025 Wed Aug 13 07:45:05 EDT 2025 Thu Apr 24 23:10:58 EDT 2025 Tue Jul 01 01:45:27 EDT 2025 Wed Jan 22 16:26:56 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3300-5ad094867087c796fe1f4bd57c897e01c6d9e91d6c10a71532f18d40ff35357a3 |
Notes | All authors have nothing to declare. Declaration of conflict of interest Financial support Science and Technology Project of Shaanxi Province (2021ZDLSF02‐09), Youth Project of Science and Technology Department of Shaanxi Province (2022JQ‐986), and Shaanxi Provincial Department of Education 2020 Special Scientific Research Plan for Emergency Public Health Safety (20JG028). GT is supported in part by grants from the School of Medicine, University of Verona, Verona, Italy. CDB is supported in part by the Southampton NIHR Biomedical Research Centre (IS‐BRC‐20004), UK. Gong Feng and Na He are co‐first authors. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-4984-2631 |
PQID | 2737220299 |
PQPubID | 2045136 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2688085117 proquest_journals_2737220299 crossref_primary_10_1111_jgh_15940 crossref_citationtrail_10_1111_jgh_15940 wiley_primary_10_1111_jgh_15940_JGH15940 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | November 2022 2022-11-00 20221101 |
PublicationDateYYYYMMDD | 2022-11-01 |
PublicationDate_xml | – month: 11 year: 2022 text: November 2022 |
PublicationDecade | 2020 |
PublicationPlace | Richmond |
PublicationPlace_xml | – name: Richmond |
PublicationTitle | Journal of gastroenterology and hepatology |
PublicationYear | 2022 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2022; 199 2017; 8 2015; 14 2013; 22 2017; 47 2006; 10 2019; 10 2019; 98 2018; 201 2021; 28 2018; 203 2022; 68 2020; 742 2019; 18 2020; 13 2020; 12 2021; 71 2021; 52 2021; 73 2015; 7 2020; 408 2020; 19 2018; 68 2014; 355 2016; 5 2018; 391 2019; 40 2021; 12 2022 2020; 132 2020; 71 2021; 19 2022; 12 2019; 179 2019; 378 2022; 97 2015 2018; 34 2012; 42 2017; 127 2022; 18 2018; 58 2012; 85 e_1_2_6_32_1 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_30_1 e_1_2_6_19_1 Zhou A (e_1_2_6_36_1) 2020; 13 Kang L (e_1_2_6_35_1) 2020; 12 e_1_2_6_13_1 e_1_2_6_14_1 e_1_2_6_11_1 e_1_2_6_34_1 e_1_2_6_12_1 e_1_2_6_33_1 e_1_2_6_18_1 e_1_2_6_39_1 e_1_2_6_15_1 e_1_2_6_38_1 e_1_2_6_16_1 e_1_2_6_37_1 e_1_2_6_42_1 e_1_2_6_43_1 Chan EE (e_1_2_6_17_1) 2017; 47 e_1_2_6_21_1 e_1_2_6_20_1 e_1_2_6_41_1 e_1_2_6_40_1 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_29_1 e_1_2_6_44_1 e_1_2_6_28_1 e_1_2_6_45_1 e_1_2_6_27_1 e_1_2_6_26_1 |
References_xml | – volume: 40 start-page: 305 year: 2019 end-page: 317 article-title: Molecular subtyping of cancer and nomination of kinase candidates for inhibition with phosphoproteomics: Reanalysis of CPTAC ovarian cancer publication-title: EBioMedicine – volume: 355 start-page: 264 year: 2014 end-page: 272 article-title: Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway publication-title: Cancer Lett. – volume: 18 start-page: 579 year: 2022 end-page: 596 article-title: Identification of PYGL as a key prognostic gene of glioma by integrated bioinformatics analysis publication-title: Future Oncol. – volume: 13 start-page: 415 year: 2020 end-page: 426 article-title: Comprehensive Evaluation of Endocytosis‐Associated Protein SCAMP3 in Hepatocellular Carcinoma publication-title: Pharmgenomics Pers Med. – volume: 19 start-page: 68 year: 2020 article-title: Development and validation of a RNA binding protein gene pair‐associated prognostic signature for prediction of overall survival in hepatocellular carcinoma publication-title: Biomed. Eng. Online – volume: 5 year: 2016 article-title: Proteomics: A new perspective for cancer publication-title: Adv. Biomed. Res. – volume: 97 year: 2022 article-title: Predicting the evolution of number of native contacts of a small protein by using deep learning approach publication-title: Comput. Biol. Chem. – volume: 73 start-page: 4 year: 2021 end-page: 13 article-title: Epidemiology of Hepatocellular Carcinoma publication-title: Hepatology – volume: 19 start-page: 5008 year: 2021 end-page: 5018 article-title: Machine learning and deep learning methods that use omics data for metastasis prediction publication-title: Comput. Struct. Biotechnol. J. – volume: 127 start-page: 137 year: 2017 end-page: 152 article-title: Hippo signaling interactions with Wnt/β‐catenin and Notch signaling repress liver tumorigenesis publication-title: J. Clin. Invest. – volume: 8 start-page: 89978 year: 2017 end-page: 89987 article-title: Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection publication-title: Oncotarget – volume: 18 start-page: 1893 year: 2019 end-page: 1898 article-title: Integration and Analysis of CPTAC Proteomics Data in the Context of Cancer Genomics in the cBioPortal publication-title: Mol. Cell. Proteomics – volume: 12 start-page: 7870 year: 2020 end-page: 7884 article-title: SCAMP3 is regulated by miR‐128‐3p and promotes the metastasis of hepatocellular carcinoma cells through EGFR‐MAPK p38 signaling pathway publication-title: Am J Transl Res. – volume: 201 start-page: 3770 year: 2018 end-page: 3779 article-title: IL‐33 Released in the Liver Inhibits Tumor Growth via Promotion of CD4(+) and CD8(+) T Cell Responses in Hepatocellular Carcinoma publication-title: J. Immunol. – volume: 68 start-page: 686 year: 2022 end-page: 698 article-title: Identification of Serum Biomarkers in Patients with Alzheimer's Disease by 2D‐DIGE Proteomics publication-title: Gerontology – volume: 28 start-page: 493 year: 2021 end-page: 507 article-title: Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis publication-title: J. Viral Hepat. – volume: 391 start-page: 1023 year: 2018 end-page: 1075 article-title: Global surveillance of trends in cancer survival 2000‐14 (CONCORD‐3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population‐based registries in 71 countries publication-title: Lancet – volume: 47 start-page: 287 year: 2017 end-page: 293 article-title: A review of prognostic scores after liver resection in hepatocellular carcinoma: the MSKCC, SLICER and SSCLIP scores publication-title: Jpn. J. Clin. Oncol. – volume: 58 start-page: 1533 year: 2018 end-page: 1543 article-title: Toxic Colors: The Use of Deep Learning for Predicting Toxicity of Compounds Merely from Their Graphic Images publication-title: J. Chem. Inf. Model. – volume: 12 year: 2021 article-title: Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies publication-title: Front. Immunol. – volume: 22 start-page: 819 year: 2013 end-page: 826 article-title: Heart research advances using database search engines, Human Protein Atlas and the Sydney Heart Bank publication-title: Heart Lung Circ. – volume: 10 start-page: 2510 year: 2019 article-title: CHML promotes liver cancer metastasis by facilitating Rab14 recycle publication-title: Nat. Commun. – volume: 68 start-page: 1025 year: 2018 end-page: 1041 article-title: Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification publication-title: Hepatology – volume: 14 start-page: 2707 year: 2015 end-page: 2713 article-title: The CPTAC Data Portal: A Resource for Cancer Proteomics Research publication-title: J. Proteome Res. – volume: 85 start-page: 1333 year: 2012 end-page: 1345 article-title: An improved swarm optimized functional link artificial neural network (ISO‐FLANN) for classification publication-title: Journal of Systems and Software. – volume: 71 start-page: 1093 year: 2020 end-page: 1105 article-title: Applying Machine Learning in Liver Disease and Transplantation: A Comprehensive Review publication-title: Hepatology – volume: 10 start-page: 99 year: 2006 end-page: 111 article-title: Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment publication-title: Cancer Cell – volume: 742 year: 2020 article-title: Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis publication-title: Gene – year: 2022 article-title: Mass spectrometry‐based proteomics for abiotic stress studies publication-title: Trends Plant Sci. – volume: 203 start-page: 810 year: 2018 end-page: 821 article-title: Predictive modelling for solar thermal energy systems: A comparison of support vector regression, random forest, extra trees and regression trees publication-title: J. Clean. Prod. – volume: 199 start-page: 243 year: 2022 end-page: 251 article-title: Potential protein markers in children with Autistic Spectrum Disorder (ASD) revealed by salivary proteomics publication-title: Int. J. Biol. Macromol. – volume: 28 start-page: 593 year: 2021 end-page: 603 article-title: Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy‐confirmed NAFLD publication-title: J. Hepatobiliary Pancreat. Sci. – volume: 7 start-page: 19 year: 2015 end-page: 33 article-title: VSURF: An R Package for Variable Selection Using Random Forests publication-title: R. J. – volume: 98 year: 2019 article-title: Clinicopathologic and prognostic significance of tumor‐infiltrating CD8+ T cells in patients with hepatocellular carcinoma: A meta‐analysis publication-title: Medicine (Baltimore). – volume: 179 start-page: 561 year: 2019 end-page: 77 e22 article-title: Integrated Proteogenomic Characterization of HBV‐Related Hepatocellular Carcinoma publication-title: Cell – volume: 52 start-page: 1223 year: 2021 end-page: 1231 article-title: Prognostic Factors of Liver Transplantation for HCC: Comparative Literature Review publication-title: J. Gastrointest. Cancer – volume: 408 start-page: 189 year: 2020 end-page: 215 article-title: A comprehensive survey on support vector machine classification: Applications, challenges and trends publication-title: Neurocomputing. – volume: 378 start-page: 41 year: 2019 end-page: 50 article-title: TNF‐α derived from M2 tumor‐associated macrophages promotes epithelial‐mesenchymal transition and cancer stemness through the Wnt/β‐catenin pathway in SMMC‐7721 hepatocellular carcinoma cells publication-title: Exp. Cell Res. – volume: 12 year: 2022 article-title: Machine Learning Applied to Omics Datasets Predicts Mortality in Patients with Alcoholic Hepatitis publication-title: Metabolites. – volume: 42 start-page: 515 year: 2012 end-page: 525 article-title: Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database publication-title: Surg. Today – volume: 34 start-page: 1615 year: 2018 end-page: 1617 article-title: TCGA‐assembler 2: software pipeline for retrieval and processing of TCGA/CPTAC data publication-title: Bioinformatics (Oxford, England). – volume: 132 start-page: 379 year: 2020 end-page: 394 article-title: Artificial Intelligence in Anesthesiology: Current Techniques, Clinical Applications, and Limitations publication-title: Anesthesiology – year: 2015 – volume: 71 start-page: 209 year: 2021 end-page: 249 article-title: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries publication-title: CA Cancer J. Clin. – ident: e_1_2_6_45_1 doi: 10.1016/j.ccr.2006.06.016 – ident: e_1_2_6_15_1 doi: 10.1002/jhbp.972 – ident: e_1_2_6_21_1 doi: 10.1007/s00595-012-0167-z – ident: e_1_2_6_37_1 doi: 10.1172/JCI88486 – ident: e_1_2_6_31_1 doi: 10.1016/j.gene.2020.144549 – ident: e_1_2_6_34_1 doi: 10.1186/s12938-020-00812-0 – ident: e_1_2_6_24_1 doi: 10.1016/j.jclepro.2018.08.207 – ident: e_1_2_6_32_1 doi: 10.32614/RJ-2015-018 – ident: e_1_2_6_16_1 doi: 10.1002/hep.31103 – ident: e_1_2_6_43_1 doi: 10.1016/j.canlet.2014.09.026 – ident: e_1_2_6_41_1 doi: 10.1097/MD.0000000000013923 – ident: e_1_2_6_40_1 doi: 10.4049/jimmunol.1800627 – ident: e_1_2_6_29_1 doi: 10.1016/j.jss.2012.01.025 – volume: 47 start-page: 287 year: 2017 ident: e_1_2_6_17_1 article-title: A review of prognostic scores after liver resection in hepatocellular carcinoma: the MSKCC, SLICER and SSCLIP scores publication-title: Jpn. J. Clin. Oncol. – ident: e_1_2_6_4_1 doi: 10.3322/caac.21660 – ident: e_1_2_6_11_1 doi: 10.1016/j.tplants.2021.12.013 – ident: e_1_2_6_25_1 doi: 10.3390/metabo12010041 – ident: e_1_2_6_26_1 doi: 10.1016/j.neucom.2019.10.118 – ident: e_1_2_6_33_1 – volume: 13 start-page: 415 year: 2020 ident: e_1_2_6_36_1 article-title: Comprehensive Evaluation of Endocytosis‐Associated Protein SCAMP3 in Hepatocellular Carcinoma publication-title: Pharmgenomics Pers Med. – ident: e_1_2_6_2_1 doi: 10.1111/jvh.13452 – ident: e_1_2_6_9_1 doi: 10.1159/000520961 – ident: e_1_2_6_18_1 doi: 10.1021/pr501254j – ident: e_1_2_6_10_1 doi: 10.1016/j.ijbiomac.2022.01.011 – ident: e_1_2_6_38_1 doi: 10.1038/s41467-019-10364-0 – ident: e_1_2_6_44_1 doi: 10.3389/fimmu.2021.655697 – ident: e_1_2_6_14_1 doi: 10.1093/bioinformatics/btx812 – ident: e_1_2_6_30_1 doi: 10.1016/j.compbiolchem.2022.107625 – ident: e_1_2_6_3_1 doi: 10.1007/s12029-021-00730-x – ident: e_1_2_6_7_1 doi: 10.18632/oncotarget.21208 – ident: e_1_2_6_23_1 doi: 10.1097/ALN.0000000000002960 – ident: e_1_2_6_6_1 doi: 10.1002/hep.31288 – ident: e_1_2_6_22_1 doi: 10.2217/fon-2021-0759 – ident: e_1_2_6_5_1 doi: 10.1016/S0140-6736(17)33326-3 – ident: e_1_2_6_12_1 doi: 10.1074/mcp.TIR119.001673 – ident: e_1_2_6_28_1 doi: 10.1016/j.csbj.2021.09.001 – ident: e_1_2_6_42_1 doi: 10.1016/j.yexcr.2019.03.005 – ident: e_1_2_6_19_1 doi: 10.1016/j.cell.2019.08.052 – ident: e_1_2_6_8_1 doi: 10.4103/2277-9175.180636 – ident: e_1_2_6_20_1 doi: 10.1016/j.hlc.2013.06.006 – volume: 12 start-page: 7870 year: 2020 ident: e_1_2_6_35_1 article-title: SCAMP3 is regulated by miR‐128‐3p and promotes the metastasis of hepatocellular carcinoma cells through EGFR‐MAPK p38 signaling pathway publication-title: Am J Transl Res. – ident: e_1_2_6_27_1 doi: 10.1021/acs.jcim.8b00338 – ident: e_1_2_6_13_1 doi: 10.1016/j.ebiom.2018.12.039 – ident: e_1_2_6_39_1 doi: 10.1002/hep.29904 |
SSID | ssj0004075 |
Score | 2.4194279 |
Snippet | Background and Aim
Over 10% of hepatocellular carcinoma (HCC) cases recur each year, even after surgical resection. Currently, there is a lack of knowledge... Background and AimOver 10% of hepatocellular carcinoma (HCC) cases recur each year, even after surgical resection. Currently, there is a lack of knowledge... Over 10% of hepatocellular carcinoma (HCC) cases recur each year, even after surgical resection. Currently, there is a lack of knowledge about the causes of... |
SourceID | proquest crossref wiley |
SourceType | Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 2145 |
SubjectTerms | Algorithms CPTAC database Hepatitis Hepatitis B Hepatocellular carcinoma Learning algorithms Liver cancer Machine learning machine learning models Prediction models Proteins Proteomics recurrence of hepatocellular carcinoma Survival Survival analysis Tumors |
Title | Machine learning algorithms based on proteomic data mining accurately predicting the recurrence of hepatitis B‐related hepatocellular carcinoma |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjgh.15940 https://www.proquest.com/docview/2737220299 https://www.proquest.com/docview/2688085117 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Pb9MwFLeqHiYuYwMmOgoyiAOXVHbixIk4AWJUk8pholIPSJH_pa3WJqhND9tpHwG-Ip-E95yk2xBIiFuUvDiO_f7Zfu_3CHnNuRI6ZFlgUqsxJUcHisUmsFql0sZCFL5qyeRzMp6K81k865G3XS5Mgw-x33BDyfD6GgVc6e1dIZ8vRmCLBa7XMVYLHaKLW-go0YDsgsWLgwz4rEUV8lE83Zv3bdGtg3nXTfV25uwh-dr1sAkvuRztaj0y17-BN_7nLxyRw9b_pO8ahjkmPVc-IgeT9oT9Mfkx8dGVjrblJOZUrebVZlkv1luKJs_SqqQe3QHzmSlGmNL1sqE0ZofIE6srIMAWMaSagodJN7ir7_MKaVXQhcMw7nq5pe9_3nz32TTQrL9b4UECRsZSg0WOymqtnpDp2ccvH8ZBW7YhMFHEWBArC2vGNJEslUZmSeF4IbSNpUkz6Rg3ic1cxm1iOFMSNG5Y8NQKVgBbRLFU0Qnpl1XpnhIK06idioxIVCgiG2fGgAqyBY8KrkGPD8ibbgJz02KaY2mNVb5f28wXuR_iAXm1J_3WAHn8iWjYcUHeyvI2D7GST8jAbg_Iy_1jkEIcEVW6agc0CehBdF4ldMlP-d8_kp9_GvuL038nfUYehJh34ZMgh6Rfb3buOXhDtX7h2f4X45YJDA |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtNAFL0qRQI2vCsCBQYEEhtHfow99oIFUEr6SBeolboz83ISkdgocYTKik-A_-BX-Am-hHvHdloQSGy6YGfZV-PR-L5mfO65AE-CQHIV-pmnU6OoJEd50o-1Z5RMhYk5L1zXkuFBMjjiu8fx8Rp862phGn6I1YEbWYbz12TgdCB91spH4z4GY-63kMo9e_IRN2yL5ztb-HWfhuH268NXA6_tKeBp3Ln7XiwNbmjSRPip0CJLChsUXJlY6DQT1g90YjKbBSbRgS8FuoOwCFLD_QLnHMVCRjjuBbhIHcSJqX_r7SlZFW9ofTHGxl6Gmt3yGDncUDfVX6PfaUp7NjF2kW37Gnzv1qQBtLzvL2vV159-o4v8XxbtOlxtU2z2orGJG7Bmy5twadiCCG7B16EDkFrWdswYMTkdVfNJPZ4tGEV1w6qSOQILKtlmBKJls0kjqfWSyDWmJyhAIxJqnGESzeb048KVTrKqYGNLSPV6smAvf3z-4gqGcFh3t6J_JQT-ZZr6OJXVTN6Go3NZkA1YL6vS3gGGeqOsjDRPZMgjE2dao5c1RRAVgcJQ1YNnncbkuqVtp-4h03y1fRuNc_dJe_B4Jfqh4Sr5k9Bmp3Z5664WeUjNikIfU5MePFo9RkdDKyJLWy1RJkFXT_m5wCk5Hfv7S_LdNwN3cfffRR_C5cHhcD_f3znYuwdXQiozcTWfm7Bez5f2PiZ_tXrgbI7Bu_PW158dnWTG |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtNAEB6VIlVcyr8aKLAgkLg4WtvrvwMHIA1pSyqEqNSbWe-uk6iJXSWOUDnxCPAcvApPwZN0Zm2nBYHEpQdulj1ar9bzt95vvgF46rpSZB5PHBXrjEpyMkfyQDk6k3GkAyFy27VkeBAODsXeUXC0Bt_bWpiaH2L1w40sw_prMvATnV808tG4i7FY8AZRuW9OP-F-bfFit4cf95nn9Xc-vB44TUsBR-HGnTuB1LificOIx5GKkjA3bi4yHUQqTiLDXRXqxCSuDpXLZYTewMvdWAue45T9IJI-jnsFroqQJ9Qnovf-nKtK1Ky-GGIDJ0HFbmiMLGyoneqvwe88o72YF9vA1r8OP9olqfEsx91llXXV59_YIv-TNbsBm02CzV7WFnET1kxxCzaGDYTgNnwbWvioYU2_jBGT01E5n1Tj2YJRTNesLJilr6CCbUYQWjab1JJKLYlaY3qKAjQiYcYZptBsTscWtnCSlTkbG8KpV5MFe_Xzy1dbLoTD2rslnZQQ9Jcp6uJUlDN5Bw4vZUHuwnpRFmYLGKpNZqSvRCg94esgUQp9rM5dP3czDFQdeN4qTKoa0nbqHTJNV5u30Ti1n7QDT1aiJzVTyZ-EtlutSxtntUg9alXkcUxMOvB49RjdDK2ILEy5RJkQHT1l5xFOyarY31-S7r0Z2It7_y76CDbe9frp292D_ftwzaMaE1vwuQ3r1XxpHmDmV2UPrcUx-HjZ6noGdwVjdQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Machine+learning+algorithms+based+on+proteomic+data+mining+accurately+predicting+the+recurrence+of+hepatitis+B-related+hepatocellular+carcinoma&rft.jtitle=Journal+of+gastroenterology+and+hepatology&rft.au=Feng%2C+Gong&rft.au=He%2C+Na&rft.au=Xia%2C+Harry+Hua-Xiang&rft.au=Mi%2C+Man&rft.date=2022-11-01&rft.issn=1440-1746&rft.eissn=1440-1746&rft.volume=37&rft.issue=11&rft.spage=2145&rft_id=info:doi/10.1111%2Fjgh.15940&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0815-9319&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0815-9319&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0815-9319&client=summon |